NIH-funded research R21 grant

How opioid medications may affect thinking and brain health in people with HIV

Official title: How Buprenorphine and Methadone Differentially Shape Cognitive Outcomes in HIV

Funded at Virginia Commonwealth University · NIH-11474460 · Data updated 2026-11-12

This NIH grant tests whether buprenorphine or methadone have different effects on thinking skills and brain health in a model that mimics HIV.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionVirginia Commonwealth University
NIH-funded
Lab location1 site (Richmond, United States)
Project startSeptember 1, 2026
Project endAugust 31, 2028
Funding year2026
Award (this year)$426,938
NIH project number1R21DA067366-01
Project IDNIH-11474460 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with HIV and opioid use disorder who may later participate in human studies or trials building on this work.

Less likely to help

Patients without HIV or without opioid use disorder may not experience direct benefits from these findings.

What this research studies

Researchers will compare two opioid treatments, buprenorphine and methadone, to see how they influence learning, memory, brain barrier integrity, and neuroinflammation in a mouse model of HIV. The study uses the EcoHIV mouse to simulate HIV infection and examines how each medication interacts with antiretroviral therapy. Two aims run in parallel to measure cognitive performance and neuropathology under opioid dependence. Findings could clarify which treatment might support better brain health for people living with HIV and OUD.

Why it matters

Potential benefit: If successful, results could guide safer, more brain-friendly treatment choices for people with HIV and opioid use disorder.

How similar studies have gone: Preliminary human data suggest differences between buprenorphine and methadone in cognitive outcomes, but animal-model confirmation is needed.

Where this research is happening

  • Virginia Commonwealth University
    Richmond, United States
    Active

Researchers

  • Principal investigator: Mcrae, Mary Peace — Virginia Commonwealth University
  • Study coordinator: Mcrae, Mary Peace

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.